Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.38 USD | -3.50% | -3.70% | -14.34% |
04-16 | Precision BioSciences Opts to Regain Rights to 3 Programs From Eli Lilly Unit Collaboration | MT |
04-16 | Transcript : Precision BioSciences, Inc. - Special Call |
Business Summary
Number of employees: 109
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Gene Editing
100.0
%
| 25 | 100.0 % | 49 | 100.0 % | +94.15% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 25 | 100.0 % | 49 | 100.0 % | +94.15% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Amoroso
CEO | Chief Executive Officer | 46 | 14/10/21 |
Jeff Smith
FOU | Founder | - | 25/01/06 |
John Kelly
DFI | Director of Finance/CFO | 57 | 13/10/20 |
Sinu Bhandaru
COO | Chief Operating Officer | - | 31/07/17 |
Alan List
CTO | Chief Tech/Sci/R&D Officer | 69 | 25/04/21 |
Mei Burris
AUD | Comptroller/Controller/Auditor | - | 31/01/19 |
Juli Blanche
HRO | Human Resources Officer | - | 22/05/22 |
Cindy Atwell
PRN | Corporate Officer/Principal | - | 31/12/18 |
Dario Scimeca
LAW | General Counsel | 49 | 11/06/19 |
Neil Leatherbury
PRN | Corporate Officer/Principal | - | 31/12/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Buehler
CHM | Chairman | 66 | 07/11/19 |
Geno Germano
BRD | Director/Board Member | 63 | 09/03/20 |
Director/Board Member | 75 | 05/11/21 | |
Melinda Brown
BRD | Director/Board Member | - | 30/05/22 |
Michael Amoroso
CEO | Chief Executive Officer | 46 | 14/10/21 |
Stanley Frankel
BRD | Director/Board Member | 65 | 11/04/21 |
Shari Lisa Piré
BRD | Director/Board Member | 59 | 05/11/21 |
Company contact information
Precision BioSciences, Inc.
Dibrell Building 302 East Pettigrew Street
27701, Durham
+919 314 5512
http://www.precisionbiosciences.comSector
EPS Revisions
- Stock Market
- Equities
- DTIL Stock
- Company Precision BioSciences, Inc.